van den Berg M P, van de Ven L L, Witting W, Crijns H J, Haaksma J, Bel K J, de Langen C D, Lie K I
Department of Cardiology, University of Groningen, The Netherlands.
Jpn Heart J. 1997 Nov;38(6):841-8. doi: 10.1536/ihj.38.841.
Despite their widespread use in atrial fibrillation, the effects of beta-adrenoceptor blockers on atrial and atrioventricular (AV) nodal refractoriness, and atrial fibrillatory rate during atrial fibrillation have been incompletely characterised. In particular, it is unknown whether additional sodium channel (class I) blocking effects play a role. Effects of bisoprolol (no class I effect) and metoprolol (mild class I effect) were therefore compared in 12 open-chest pigs. Atrial and AV-nodal effective refractory periods were determined at pacing cycle length 500 ms and 300 ms. Atrial fibrillation was then induced by premature stimulation and topical application of metacholine, and atrial fibrillatory intervals and ventricular intervals were recorded. After resumption of sinus rhythm, bisoprolol 0.1 mg/kg or metoprolol 0.3 mg/kg was administered, and measurements were repeated. Also, effects on plasma catecholamines and signal-averaged QRS duration were determined. Both bisoprolol and metoprolol prolonged atrial and AV-nodal effective refractory periods at both pacing cycle lengths, however, no differences were noted between the two drugs. No significant effects were observed on atrial and ventricular intervals during atrial fibrillation. Plasma catecholamines were low and unaffected by either drug, as was the QRS duration. It is concluded that the mild class I effect of metoprolol does not play a role in atrial fibrillation. Also, the results confirm the clinical notion that beta-blockers exert insignificant effects during atrial fibrillation in the setting of low sympathetic tone.
尽管β-肾上腺素能受体阻滞剂在心房颤动中广泛应用,但其对心房及房室(AV)结不应期以及心房颤动时心房颤动率的影响尚未完全明确。特别是,尚不清楚额外的钠通道(I类)阻滞作用是否起作用。因此,在12只开胸猪中比较了比索洛尔(无I类作用)和美托洛尔(轻度I类作用)的效果。在起搏周期长度为500毫秒和300毫秒时测定心房和房室结有效不应期。然后通过过早刺激和局部应用乙酰甲胆碱诱发心房颤动,并记录心房颤动间隔和心室间隔。恢复窦性心律后,给予比索洛尔0.1毫克/千克或美托洛尔0.3毫克/千克,并重复测量。此外,还测定了对血浆儿茶酚胺和信号平均QRS时限的影响。比索洛尔和美托洛尔在两个起搏周期长度下均延长了心房和房室结有效不应期,然而,两种药物之间未观察到差异。在心房颤动期间,对心房和心室间隔未观察到显著影响。血浆儿茶酚胺水平较低,且不受任何一种药物的影响,QRS时限也是如此。结论是美托洛尔的轻度I类作用在心房颤动中不起作用。此外,结果证实了临床观点,即在交感神经张力较低的情况下,β受体阻滞剂在心房颤动期间发挥的作用不显著。